Omolayo Tinuke Umaru

Dr. Omolayo Tinuke Umaru

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2024 in Pharmacy
Verified
Journal Article
Open access
PDF file
OOOlihe Okoro
Olihe Okoro
Omolayo Tinuke UmaruOmolayo Tinuke Umaru
Omolayo Tinuke Umaru
MRMeghana Ray
Meghana Ray
Women of color (WoC) in the health professions encounter challenges in advancement to higher positions, disparities in wages, discrimination, lack of expectation to achieve leadership positions, and absence of extensive support networks. Articles in the literature have addressed race and/or gender in the context of professional development. However, applying an intersectional lens or framework to better understand the contextual issues of professional development for WoC remains to be addressed. Thus, this scoping review aimed to (i) identify health professions literature that addresses disparities affecting WoC, and (ii) describe strategies and approaches to support WoC in the health professions. Methods: The literature searches were conducted in multiple databases, including PubMed and MEDLINE (Ovid); and Google and Google Scholar were used to “hand search” further articles including gray literature. Three independent reviewers reviewed and screened articles for inclusion in accordance with a guide. Search included articles on pharmacy or healthcare professions, published in English, and which met three content criteria: racial disparities/inequities, professional development/career advancement, and women or gender disparities Results: A total of 31 articles were included—medicine (17), nursing (1), pharmacy (7), other (4), and multiple health professions (2). Key findings included underrepresentation of women and minority groups, inequities in professional advancement and leadership positions for WoC, and greater dissatisfaction and attrition among minority and women professionals. Conclusion: WoC face unique and distinct challenges and barriers in their professional careers resulting from the intersectionality of not only race and gender, but also lived experiences and opportunities. Strategies to improve diversity and representation should include an intersectional framework or lens and be critically evaluated.

18 March 2026 in Pharmacy
Verified
Journal Article
Open access
PDF file
Omolayo Tinuke UmaruOmolayo Tinuke Umaru
Omolayo Tinuke Umaru
AAAdebowale Sylvester Adeyemi
Adebowale Sylvester Adeyemi
OAOlajumoke Aderonmu
Olajumoke Aderonmu
BBBalyodh Singh Bhangu
Balyodh Singh Bhangu
HDHarjot Singh Dhaliwal
Harjot Singh Dhaliwal
TATaiwo Opeyemi Aremu
Taiwo Opeyemi Aremu
Pharmaceutical regulation plays a central role in protecting public health by governing clinical trials, market authorization, and post-marketing safety monitoring throughout the medicine life cycle. While substantial literature describes established systems, particularly the United States Food and Drug Administration (FDA), Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), and the European medicines regulatory network coordinated by the European Medicines Agency (EMA) together with national competent authorities, comparative analyses that integrate both mature authorities, emerging regulators and transnational harmonization networks remain limited. This narrative review draws on primary regulator/network documentation and targeted peer-reviewed literature to compare core regulatory functions across jurisdictions, including approval pathways and evidentiary expectations, inspection and good manufacturing practice (GMP) oversight, transparency practices, and pharmacovigilance and risk-management approaches. Across regions, we observe increasing convergence in scientific expectations through initiatives such as the International Council for Harmonisation (ICH) and reliance and work-sharing models, alongside persistent differences in legal mandates, resourcing, timelines, and data requirements. These differences are most consequential for complex products (e.g., advanced therapies) and in crisis settings, where emergency or conditional authorizations amplify the need for strong lifecycle monitoring, real-world evidence governance, and cross-border communication. We conclude by outlining opportunities to strengthen regulatory resilience and equity through fit-for-purpose harmonization, investment in enabling infrastructure, and future work on interoperable data systems, signal detection, and coordinated post-marketing evaluation.

30 October 2023 in Journal of Contemporary Studies in Epidemiology and Public Health
Verified
Journal Article
Open access
PDF file
AIAduke Elizabeth Ipingbemi
Aduke Elizabeth Ipingbemi
OAOluwatorinmo Oluseyi Ajanaku
Oluwatorinmo Oluseyi Ajanaku
Omolayo Tinuke UmaruOmolayo Tinuke Umaru
Omolayo Tinuke Umaru
The consequences of unwanted pregnancy are a public health concern and the knowledge of pharmacists on contraceptives is important being the most accessed healthcare provider. The study assessed the knowledge of community pharmacists in Ibadan, Oyo State, Nigeria on oral contraceptives and counselling practices during dispensing of the same. 110 community pharmacists were assessed using self-administered questionnaires. Data collected include socio-demographics, knowledge, and current counselling practices of participants on contraceptives. Data was entered into IBM-SPSS version 23 and analyzed using descriptive and inferential statistics. Chi-square was used to determine the association between socio-demographic characteristics, knowledge and counselling practices of participants. 130 questionnaires were distributed and 110 were retrieved giving a response rate of 84.6%. There were more males (64, 58.2%) than females and the mean age of participants was 32.72±9.00 years. The majority (92, 83.6%) had only their first degree. Participants’ knowledge of oral contraceptives was found to be high with 80 (72.7%) having good knowledge while 27 (24.5%) had good counselling practices. There was no significant association between socio-demographics and knowledge of contraceptives. Higher educational qualification had no positive influence on their counselling practices with significant number of participants with Bachelor of Pharmacy qualifications having better counseling practices (p=0.03). The knowledge of participants on the use of oral contraceptives also significantly influenced their counselling practice (p=0.03). Community pharmacists need further training on how to counsel patients on use of oral contraceptives in other to reduce unplanned pregnancy, and consequently prevent uncontrolled population growth.

29 June 2026 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Open access
PDF file
Omolayo Tinuke UmaruOmolayo Tinuke Umaru
Omolayo Tinuke Umaru
DPDeborah L. Pestka
Deborah L. Pestka
LSLindsay A. Sorge
Lindsay A. Sorge
CCChi‐Han Cheng
Chi‐Han Cheng
KDKate Dryden
Kate Dryden
WSWendy StPeter
Wendy StPeter
Background: Obesity, diabetes, and cardiovascular disease often co‐exist in people with chronic kidney disease, placing them at high risk for adverse health outcomes. Availability of highly effective medications that span cardiovascular‐kidney‐metabolic (CKM) conditions, but limited uptake in real world settings, calls for a new transformative practice paradigm. We sought to identify key gaps, barriers, and facilitators to implementing a standardized CKM‐focused comprehensive medication management (CMM) intervention, including needs/solutions among various care team members involved in CKM care in diverse health systems across the United States. Methods: This was a qualitative study guided by the Consolidated Framework for Implementation Research (CFIR) deployed in five health care systems across the United States. Clinical pharmacists, pharmacist administrators, primary care and specialty (nephrology, cardiology, endocrinology) physicians, and advanced practice professionals were interviewed using open‐ended questions that were informed by results from three mainly quantitative online surveys. Results: A total of 26 interviews were conducted with 42 participants. Practitioners and administrators reported many similar challenges to successfully implement CMM for people with CKM including lack of standardized CMM practice and workflow across the health system, electronic medical record integrated tools to identify and track patients with CKM, automatic pharmacist referrals, broad clinical practice agreements, and holistic CKM performance metrics, as well as pharmacist time constraints and limited reimbursement. Participants also highlighted CMM‐CKM practice facilitators including recognition across most health care professionals that CKM should be a system priority, requiring strong supportive professional relationships among physician and/or administrator champions, and tools, knowledge, and resources that could be shared with others. Conclusion: Successful implementation of a transformative, holistic CMM‐CKM interprofessional team‐practice will require a tailored implementation strategy for each health system including consolidated tools such as a CMM‐CKM Change Package, integrated with coaching, field experts, and peer‐to‐peer learning.

23 March 2025 in Journal of the American Pharmacists Association
Verified
Journal Article
Closed access
APAnn M. Philbrick
Ann M. Philbrick
Omolayo Tinuke UmaruOmolayo Tinuke Umaru
Omolayo Tinuke Umaru
SBSarah Jane Brown
Sarah Jane Brown
AHAlec Helmke
Alec Helmke
KMKathryn Momary
Kathryn Momary
VHVan Hellerslia
Van Hellerslia

18 July 2025 in Journal of the American Pharmacists Association
Verified
Journal Article
Closed access
OOOlihe Okoro
Olihe Okoro
Omolayo Tinuke UmaruOmolayo Tinuke Umaru
Omolayo Tinuke Umaru
MRMeghana Ray
Meghana Ray